Skip to main content
. 2021 Apr 28;12:620772. doi: 10.3389/fneur.2021.620772

Table 1.

Current use of DMTs among survey participants (N = 332).

DMT Number of patients, n
Dimethyl fumarate 63
Fingolimod 62
Natalizumab 60
Glatiramer acetate 42
Alemtuzumab 22
Interferon β-1a 22
Ocrelizumab 21
Teriflunomide 21
Peginterferon β-1a 10
Interferon β-1b 7
Cladribine tablets 1
Mitoxantrone 1

DMT, disease-modifying therapy.